This phenomenon has been described as an adaptive (secondary) immune resistance mechanism where the cancer cells start a suppression program via induction of regulatory molecule expression upon exposure to inflammatory mediators, such as IFN-γ [24, 25, 47]. This evidence concerns the gene IFNG and cancer.